643 related articles for article (PubMed ID: 33072135)
1. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis.
Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q
Front Immunol; 2020; 11():588079. PubMed ID: 33072135
[TBL] [Abstract][Full Text] [Related]
2. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.
Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q
BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224
[TBL] [Abstract][Full Text] [Related]
3. Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice.
Wang X; Ye T; Chen WJ; Lv Y; Hao Z; Chen J; Zhao JY; Wang HP; Cai YK
World J Gastroenterol; 2017 Dec; 23(46):8128-8139. PubMed ID: 29290650
[TBL] [Abstract][Full Text] [Related]
4. Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal Microbiota.
Deng J; Zhao L; Yuan X; Li Y; Shi J; Zhang H; Zhao Y; Han L; Wang H; Yan Y; Zhao H; Wang H; Zou F
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215376
[TBL] [Abstract][Full Text] [Related]
5. Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine.
Chen H; Ye C; Wu C; Zhang J; Xu L; Wang X; Xu C; Zhang J; Guo Y; Yao Q
Int J Biol Sci; 2023; 19(7):2097-2113. PubMed ID: 37151876
[TBL] [Abstract][Full Text] [Related]
6. Macrophage depletion using clodronate liposomes decreases tumorigenesis and alters gut microbiota in the AOM/DSS mouse model of colon cancer.
Bader JE; Enos RT; Velázquez KT; Carson MS; Nagarkatti M; Nagarkatti PS; Chatzistamou I; Davis JM; Carson JA; Robinson CM; Murphy EA
Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G22-G31. PubMed ID: 29025731
[TBL] [Abstract][Full Text] [Related]
7. Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects.
Zhao R; Coker OO; Wu J; Zhou Y; Zhao L; Nakatsu G; Bian X; Wei H; Chan AWH; Sung JJY; Chan FKL; El-Omar E; Yu J
Gastroenterology; 2020 Sep; 159(3):969-983.e4. PubMed ID: 32387495
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Berberine on the Gut Microbiota in Apc
Wang H; Guan L; Li J; Lai M; Wen X
Molecules; 2018 Sep; 23(9):. PubMed ID: 30205580
[No Abstract] [Full Text] [Related]
9. Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice.
Wang Q; Wang K; Wu W; Lv L; Bian X; Yang L; Wang Q; Li Y; Ye J; Fang D; Wu J; Jiang X; Xie J; Lu Y; Li L
Appl Microbiol Biotechnol; 2020 Jul; 104(13):5915-5928. PubMed ID: 32367312
[TBL] [Abstract][Full Text] [Related]
10. Polysaccharides isolated from Nostoc commune Vaucher inhibit colitis-associated colon tumorigenesis in mice and modulate gut microbiota.
Guo M; Li Z
Food Funct; 2019 Oct; 10(10):6873-6881. PubMed ID: 31584586
[TBL] [Abstract][Full Text] [Related]
11. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.
Yao Y; Chen H; Yan L; Wang W; Wang D
Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246
[TBL] [Abstract][Full Text] [Related]
12. Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota.
Chen H; Zhang F; Li R; Liu Y; Wang X; Zhang X; Xu C; Li Y; Guo Y; Yao Q
Biomed Pharmacother; 2020 Apr; 124():109829. PubMed ID: 31958765
[TBL] [Abstract][Full Text] [Related]
13. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.
Wong SH; Zhao L; Zhang X; Nakatsu G; Han J; Xu W; Xiao X; Kwong TNY; Tsoi H; Wu WKK; Zeng B; Chan FKL; Sung JJY; Wei H; Yu J
Gastroenterology; 2017 Dec; 153(6):1621-1633.e6. PubMed ID: 28823860
[TBL] [Abstract][Full Text] [Related]
14. Berberine regulates short-chain fatty acid metabolism and alleviates the colitis-associated colorectal tumorigenesis through remodeling intestinal flora.
Yan S; Chang J; Hao X; Liu J; Tan X; Geng Z; Wang Z
Phytomedicine; 2022 Jul; 102():154217. PubMed ID: 35660350
[TBL] [Abstract][Full Text] [Related]
15. A holistic view of gallic acid-induced attenuation in colitis based on microbiome-metabolomics analysis.
Li Y; Xie Z; Gao T; Li L; Chen Y; Xiao D; Liu W; Zou B; Lu B; Tian X; Han B; Guo Y; Zhang S; Lin L; Wang M; Li P; Liao Q
Food Funct; 2019 Jul; 10(7):4046-4061. PubMed ID: 31225554
[TBL] [Abstract][Full Text] [Related]
16. Colitis-induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity.
Ibrahim A; Hugerth LW; Hases L; Saxena A; Seifert M; Thomas Q; Gustafsson JÅ; Engstrand L; Williams C
Int J Cancer; 2019 Jun; 144(12):3086-3098. PubMed ID: 30515752
[TBL] [Abstract][Full Text] [Related]
17. Berberine combined with stachyose induces better glycometabolism than berberine alone through modulating gut microbiota and fecal metabolomics in diabetic mice.
Li CN; Wang X; Lei L; Liu MZ; Li RC; Sun SJ; Liu SN; Huan Y; Zhou T; Liu Q; Cao H; Bai GL; Han YW; Shen ZF
Phytother Res; 2020 May; 34(5):1166-1174. PubMed ID: 31833107
[TBL] [Abstract][Full Text] [Related]
18. Zerumbone Restores Gut Microbiota Composition in ETBF Colonized AOM/DSS Mice.
Cho HW; Rhee KJ; Eom YB
J Microbiol Biotechnol; 2020 Nov; 30(11):1640-1650. PubMed ID: 32958727
[TBL] [Abstract][Full Text] [Related]
19. The impact of gut microbiota manipulation with antibiotics on colon tumorigenesis in a murine model.
Lee JG; Eun CS; Jo SV; Lee AR; Park CH; Han DS
PLoS One; 2019; 14(12):e0226907. PubMed ID: 31860645
[TBL] [Abstract][Full Text] [Related]
20. AC1Q3QWB inhibits colorectal cancer progression by modulating the immune response and balancing the structure of the intestinal microbiota.
Zhu W; Li J; Chen Y; Liu Z; Zhang Q; Kang C
Int Immunopharmacol; 2023 Mar; 116():109768. PubMed ID: 36731153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
